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doi:10.1016/j.canceExtranodal NK/T lymphoma, nasal type, is an uncommon neoplasm that occurs with a higher
prevalence among Asian populations and Native American populations of Central and Southern
America. In Western countries, this tumor is extremely rare, accounting for less than 1.5% of all
non-Hodgkin lymphomas. Cytogenetic analyses have been performed only in a limited number of
cases, mainly because of technical problems related to extensive necrosis and the scarcity of
clinical samples, and these have shown complex karyotypes with no specific chromosomal trans-
locations. Here, we report the cytogenetic characterization of a clinically aggressive nasal NK/
T-cell lymphoma occurring in a 40-year-old Italian male patient, in which the sole chromosome
abnormality was a partial trisomy of chromosome 13.
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ª 2012 Elsevier Inc. All rights reserved.Extranodal NK/T lymphoma, nasal type, is one of the two
mature NK-cells-derived neoplasms reported in the most
recent World Health Organization (WHO) classification of
lymphoid tissues. Although this lymphoma is more prevalent
in Asia and Central and Southern America, some rare cases
have also been reported in Europe and North America. The
typical site of origin is the nasal cavity and upper aero-
digestive tract, which is the reason why this lymphoma has
been designated as “nasal type.” Extranasal sites of origin
include several extranodal organs, whereas solitary nodal
involvement in the absence of other localizations has been
anecdotally reported (1).
Extranodal NK/T lymphoma, nasal type, is an Epstein-Barr
virus (EBV)related neoplasmregardless of the patient’s ethnic
origin. The virus appears to play an important etiological role in
lymphomagenesis, and its detection in neoplastic cells is
a desirable criterion for a correct diagnosis (2,3).
Conventional and molecular cytogenetic analyses of this
lymphoma have only been performed in a limited number of
cases, mainly because of technical problems related tober 12, 2011; received in revised form February
February 15, 2012.
author.
silvia.uccella@uninsubria.it
front matter ª 2012 Elsevier Inc. All rights reserved.
rgen.2012.02.005extensive necrosis and the scarcity of clinical samples. No
specific pattern of chromosomal abnormalities has been
identified yet, although the most common changes are
deletion of chromosomes 6q, 8p, 11q, 12q, and 13q, and
gains of chromosomes 2q, 15q, 17q, and 22q. No specific
chromosomal translocation has been reported (4e9).
Here, we report the cytogenetic characterization of a clin-
ically aggressive nasal NK/T-cell lymphoma in a 40-year-old
Italian male patient.
Case report and histopathological
examination
A 40-year-old male patient was admitted to the otorhinolar-
yngology department of another institution because he had
nasal polyposis and chronic rhinosinusitis, for which he
underwent functional nasal surgery and ablation of inferior
turbinates. One year later, after a trip to the Sahara Desert, he
was referred to the otolaryngology department of our hospital,
with fever, persistent rhinorrhoea with crostous lesions of
nasal mucosa, and enlargement of cervical lymph nodes.
The microbiological examination of nasal samples was
positive for Streptococcus viridians and Enterococcus
faecalis group D, but serial hemocultures were negative.
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negative, as were anti-Treponema pallidum and anti-Toxo-
plasma gondi antibodies. In addition, Plasmodium falciparum
research was negative. An antibiotic therapy was started.
The ultrasonographic examination of the neck demonstrated
multiplebilateral adenopathies.Thefineneedleaspirationofone
lymph node showed atypical lymphoid cells suspect for lym-
phoproliferative disease. In this setting, the patient underwent
surgical excision of a cervical lymph node and multiple biopsies
of the nasal cavity, rhinopharynx, and paranasal sinuses.
At routine histopathological examination, the mucosal
samples were largely necrotic. In one rhinopharyngeal
biopsy, a diffuse proliferation of small and medium-sized
atypical lymphoid cells was observed, focally invading the
wall of blood vessels in an angiocentric fashion. In the lymph
node sections, the normal architecture was completely
effaced by a lymphomatous proliferation with the same
features as described in the rhinopharynx, showing focal
areas of necrosis. The immunophenotype of lymphoma cells
was CD2þ, CD3 3þ, CD56/þ, Granzyme Bþ, TIA1þ,
perforinþ and CD20, CD4, CD8, CD10, CD30,
CD57, MUM1. In situ hybridization for eeEBV-RNA
(EBER) was positive. A diagnosis of extranodal NK/T
lymphoma, nasal type, was formulated (Figure 1).
Staging procedures with a CT scan, MRI, and PET scan
revealed the presence of pathological tissue involving the
nasal mucosa and mascellar sinuses bilaterally, the peri-
rhinopharyngeal soft tissues and the left orbital cavity.
Pathological enlargement of lymph nodes at all cervical
stations was also documented. A bone marrow biopsy was
positive for lymphoma localization.Figure 1 Histopathological features of the reported nasal NK/T
a diffuse proliferation of small and medium-sized atypical lymphoid c
fashion (A) (H & E, original magnification 400). At immunohistoche
and granzyme B-positive (C) but faintly immunoreactive for CD2 (D)
(EBER) was present in the neoplastic nuclei (F).The patient underwent two cycles of chemotherapy with
the CHOP (cyclophosphamide, doxorubicin, vincristin, pred-
nisone) scheme, but no response was observed and he died
45 days after diagnosis with pulmonary progression of the
disease and septic shock. A post-mortem examination was
not performed.Cytogenetic analysis
A fresh tumor sample of the cervical lymphnodewasminced into
small pieces, incubated, and processed according to themethod
described by Tibiletti et al. (10). Conventional chromosome
analysis was performed on direct preparations that were incu-
bated for 24 hours. Slides were QFQ-banded (Q-bands by fluo-
rescence using quinacrine6) and analyzed according the
recommendations of the ISCN 2009 (11). The cytogenetic study
revealed the presence of a marker chromosome in all the
analyzed metaphases, and the neoplastic karyotype was
47,XY,þmar. Fluorescence in situ hybridization (FISH) was
performed, to better define the marker chromosome, with
commercially available probes for T-cell receptor alpha/delta
(TCRAD on 14q11), beta (TCRB on 7q34), and gamma (TCRG
on7p14) (Dako Italia S.p.A.,Milano, Italy), again according to the
procedure described by Tibiletti et al. (10). The marker chromo-
some was negative for all these probes. As expected, based on
the histologic diagnosis, no T-cell receptor rearrangement was
detected.Spectral karyotypingFISH (SKY-FISH)wasperformed
aspreviously describedbyCalabreseet al. (12), and theanalysis
defined themarker chromosome as a derivative of chromosome
13 (Figure 2). FISH performed with probes RB1 and DLEU1 forlymphoma. In non-necrotic areas, the tumor was composed of
ells, focally invading the wall of blood vessels in an angiocentric
mical analysis, lymphoma cells were strongly CD3 3-positive (B)
and CD56 (E). In situ hybridization demonstrated that EBV-RNA
Figure 2 SKY-FISH. The marker chromosome was identified
as a derivative of chromosome 13.
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(all three probes from Abbott Molecular Europe, Wiesbaden,
Germany) revealed a partial trisomy of chromosome 13.
Specifically, the marker chromosome was negative for the two
13q14 probes and was positive for the 13qter probe. The final
karyotype of the nasal NK/T-cell lymphoma was defined
as: 47,XY,þmar.ish der(13)(WCP13þ,TCRG,TCRB,Rb,
DLEU1,D13S1160þ,TCRAD).Discussion
We conducted a detailed cytogenetic analysis of a case of
extranodal NK/T lymphoma that was well characterized
from a morphological and clinical point of view. Cytogenetic
investigation revealed a partial trisomy of chromosome
13 as the sole chromosome abnormality in the neoplastic
cells. To our knowledge, this is the first report of a partial
trisomy of chromosome 13 as a single cytogenetic aberra-
tion in any type of EBV-positive NK-cell leukemia or
lymphoma since the establishment of standardized diag-
nostic criteria for NK-cell neoplasms by WHO. The most
common cytogenetic aberration reported in extranodal
nasal NK/T-cell lymphoma is loss of 6q. Conventional
cytogenetic analysis, FISH, and spectral karyotyping have
established 6q deletions, particularly deletions of 6q21,
6q23, and 6q24-27, as common recurrent aberrations in
this neoplasm (5). Additional recurrent chromosome
abnormalities include loss of 11q and 13q, loss of 17p, gain
of the X chromosome, and gain of 20q and 13q (4e6,8,9).
All these aberrations are consistently present in complex
karyotypes with multiple numeric and structural abnormali-
ties. A review of the literature revealed only one extranodal
nasal NK/T-cell lymphoma showing an isochromosome
7q10 as a single chromosome abnormality (13) and a case
of nasal NK/T-cell lymphoma with a constitutional 11q
terminal deletion and an acquired t(1;14) of the bone
marrow specimen (14). The partial trisomy of chromosome
13 is the sole chromosome abnormality in the otherwise
diploid karyotype of this case; therefore, it may be specu-
lated that it is related to the early pathogenesis of the
disease. FISH analysis demonstrated that the trisomic
region did not encompass the RB1 and DLEU1 regions.
This observation may indicate that the partial trisomy of
chromosome 13 could have originated by two hits involving
the deletion of the RB1 and DLEU1 regions and the
subsequent malsegregation of normal chromosome 13, or
vice versa. Gains of chromosome 13q in extranodal nasal
NK/T-cell lymphoma have been reported by other authors
as a part of complex karyotypes (5,6,8). Interestingly, the
described 13q gains mapped to bands 13q21 and 13q31-
33, which is the same region involved in the partial trisomy
of our case. These bands contain several unidentified
proto-oncogenes, including the G-protein-coupled receptor
18 (4,15).
In conclusion, we have reported the case of a clinically
aggressive extranodal NK/T lymphoma, nasal type, which
occurred in an Italian patient, with a unique pattern of cyto-
genetic alterations. The correlation between the partial
trisomy of chromosome 13 and the early nodal involvement,
as well as the rapidly fatal course of this lymphoma, remains
to be established.
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